These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22535710)

  • 1. Increased systemic inflammatory interleukin-1ß and interleukin-6 during agitation as predictors of Alzheimer's disease.
    Honma T; Hatta K; Hitomi Y; Kambayashi Y; Hibino Y; Konoshita T; Nakamura H
    Int J Geriatr Psychiatry; 2013 Mar; 28(3):233-41. PubMed ID: 22535710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of interleukin 6 and alpha-globulins in differentiating Alzheimer and vascular dementias.
    Helmy AA; Naseer MM; Shafie SE; Nada MA
    Neurodegener Dis; 2012; 9(2):81-6. PubMed ID: 22133543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between altered systemic inflammatory interleukin-1beta and natural killer cell activity and subsequently agitation in patients with Alzheimer disease.
    Higuchi M; Hatta K; Honma T; Hitomi YH; Kambayashi Y; Hibino Y; Matsuzaki I; Sasahara S; Nakamura H
    Int J Geriatr Psychiatry; 2010 Jun; 25(6):604-11. PubMed ID: 19728317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurobehavioral manifestation in early period of Alzheimer disease and vascular dementia].
    Bidzan M; Bidzan L
    Psychiatr Pol; 2014; 48(2):319-30. PubMed ID: 25016769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia.
    Zuliani G; Guerra G; Ranzini M; Rossi L; Munari MR; Zurlo A; Blè A; Volpato S; Atti AR; Fellin R
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):305-11. PubMed ID: 17022108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia.
    Zuliani G; Ranzini M; Guerra G; Rossi L; Munari MR; Zurlo A; Volpato S; Atti AR; Blè A; Fellin R
    J Psychiatr Res; 2007 Oct; 41(8):686-93. PubMed ID: 16600299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in Alzheimer's disease and vascular dementia.
    Angelopoulos P; Agouridaki H; Vaiopoulos H; Siskou E; Doutsou K; Costa V; Baloyiannis SI
    Int J Neurosci; 2008 Dec; 118(12):1659-72. PubMed ID: 18937113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction.
    Senanarong V; Cummings JL; Fairbanks L; Mega M; Masterman DM; O'Connor SM; Strickland TL
    Dement Geriatr Cogn Disord; 2004; 17(1-2):14-20. PubMed ID: 14560060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agitated behaviours among the institutionalized elderly with dementia: validation of the Korean version of the Cohen-Mansfield Agitation Inventory.
    Suh GH
    Int J Geriatr Psychiatry; 2004 Apr; 19(4):378-85. PubMed ID: 15065232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inflammatory markers in Alzheimer's disease and vascular dementia].
    Androsova LV; Mikhaĭlova NM; Zozulia SA; Dupin AM; Rassadina GA; Lavrent'eva NV; Kliushnik TP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(2):49-53. PubMed ID: 23528583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain interleukin-1 beta in Alzheimer's disease and vascular dementia.
    Cacabelos R; Alvarez XA; Fernández-Novoa L; Franco A; Mangues R; Pellicer A; Nishimura T
    Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):141-51. PubMed ID: 8007743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic inflammation and the risk of Alzheimer's disease and dementia: a prospective population-based study.
    Sundelöf J; Kilander L; Helmersson J; Larsson A; Rönnemaa E; Degerman-Gunnarsson M; Basun H; Lannfelt L; Basu S
    J Alzheimers Dis; 2009; 18(1):79-87. PubMed ID: 19542629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, resource utilization and costs of vascular dementia compared to Alzheimer's dementia in a population setting.
    Sicras A; Rejas J; Arco S; Flores E; Ortega G; Esparcia A; Suárez A; Gordillo MJ
    Dement Geriatr Cogn Disord; 2005; 19(5-6):305-15. PubMed ID: 15785031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vascular risk factors in demented elderly: analysis of Alzheimer Clinic materials].
    Czyzewski K; Pfeffer A; Wasiak B; Łuczywek E; Gołebiowski M; Styczyńska M; Barcikowska M
    Neurol Neurochir Pol; 2001; 35(3):405-13. PubMed ID: 11732264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for dementia in the epidemiological study of Munguialde County (Basque Country-Spain).
    Fernández Martínez M; Castro Flores J; Pérez de Las Heras S; Mandaluniz Lekumberri A; Gordejuela Menocal M; Zarranz Imirizaldu JJ
    BMC Neurol; 2008 Oct; 8():39. PubMed ID: 18922150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory hypothesis as a link between Alzheimer's disease and diabetes mellitus.
    Bozluolcay M; Andican G; Fırtına S; Erkol G; Konukoglu D
    Geriatr Gerontol Int; 2016 Oct; 16(10):1161-1166. PubMed ID: 26337250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-inflammatory cytokines IL-1β and TNF-α are not associated with plasma homocysteine concentration in Alzheimer's disease.
    Veryard L; Jones E; Weaving G; Smith E; Cheek L; Wickramasinghe A; Tabet N
    Curr Alzheimer Res; 2013 Feb; 10(2):174-9. PubMed ID: 23463936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis.
    Imfeld P; Bodmer M; Schuerch M; Jick SS; Meier CR
    Epilepsia; 2013 Apr; 54(4):700-7. PubMed ID: 23215680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease.
    Bermejo P; Martín-Aragón S; Benedí J; Susín C; Felici E; Gil P; Ribera JM; Villar AM
    Immunol Lett; 2008 May; 117(2):198-202. PubMed ID: 18367253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study.
    Ravaglia G; Paola F; Maioli F; Martelli M; Montesi F; Bastagli L; Bianchin M; Chiappelli M; Tumini E; Bolondi L; Licastro F
    Exp Gerontol; 2006 Jan; 41(1):85-92. PubMed ID: 16297587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.